Nls Pharmaceutics Ltd (NLSP) has released an update.
NLS Pharmaceutics AG has extended the maturity date of its loan agreement with Ronald Hafner until June 30, 2025, maintaining the original terms with an amendment effective from May 13, 2024. The loan amount of CHF 500,000.00, along with any accrued interest, remains unchanged as the parties solidify their commitment under Swiss jurisdiction.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
